Position in VTRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$771,450
+$200,248 QoQ
Shares Held
48,580
+14.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#351
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NOMURA ASSET MANAGEMENT CO LTD holds $72,048,993 across 11 Drug Manufacturers - Specialty & Generic names. VTRS ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
525,329 | $37,750,141 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
384,707 | $13,033,873 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
18,237 | $9,881,352 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
56,651 | $9,547,959 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
53,978 | $934,359 | |
| 6 | VTRS |
Viatris Inc
This page
|
48,580 | $771,450 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
2,860 | $70,384 | |
| 8 | PRGO |
PERRIGO Co plc
|
2,900 | $30,131 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $771,450 | 48,580 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $571,202 | 42,280 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $766,422 | 61,560 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $580,179 | 58,604 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $533,362 | 59,727 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,399,164 | 390,260 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $4,741,209 | 380,820 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $4,378,572 | 377,138 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $3,633,227 | 341,790 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,078,751 | 341,604 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,845,808 | 355,107 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,205,880 | 325,140 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $3,253,200 | 325,972 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,522,497 | 366,164 | Shares | Sole | 2025-01-10 | |
| 2022-12-31 | $4,370,906 | 392,714 | Shares | Sole | 2025-01-10 | |
| 2022-09-30 | $3,054,948 | 358,562 | Shares | Sole | 2025-01-10 | |
| 2022-06-30 | $3,127,807 | 298,740 | Shares | Sole | 2025-01-10 | |
| 2022-03-31 | $3,053,145 | 280,620 | Shares | Sole | 2025-01-10 | |
| 2021-12-31 | $3,564,221 | 263,431 | Shares | Sole | 2025-01-10 | |
| 2021-09-30 | $3,497,078 | 258,087 | Shares | Sole | 2025-01-10 | |
| 2021-06-30 | $3,684,390 | 257,830 | Shares | Sole | 2025-01-10 | |
| 2021-03-31 | $3,426,659 | 245,287 | Shares | Sole | 2025-01-10 | |
| 2020-12-31 | $4,946,515 | 263,955 | Shares | Sole | 2025-01-10 | |
| No filing history on record for this holder in this stock. | ||||||